The theme of innovation in optometry was front and center at the second annual Ophthalmic Innovation Summit (OIS@SECO), held March 4 in Atlanta. The meeting brought together industry representatives and expert clinicians who discussed the future of vision care through a variety of presentations and panel discussions.

The agenda was divided into sections that addressed “The Evolution of Dry Eye Management,” “The Coming Era for Advancements in Glaucoma Therapies” and “Collaborative Care in Cataracts & Ocular Surface Disease.” Each section included company presentations followed by a panel of doctors who shared their expert perspectives.

In addition, OIS@SECO featured two “Innovation Showcases,” comprised of various six-minute presentations in which industry representatives provided glimpses into the future of vision by discussing technologies that address dry eye, the ocular surface, myopia management, preservative-free therapies, AMD diagnosis and treatment, drug delivery, contact lenses and low vision, among others.

The event concluded with an “Industry Insights Innovation” panel. For the complete agenda, visit https://ois.net/ois-seco-2020/agenda/ .

Event sponsors: Allergan, Azura Ophthalmics, Eyenovia, Novartis, Oyster Point Pharma, Sight Sciences, Sightglass Vision, TearClear and Zeiss. For information on OIS events, as well as the OIS newsletter and OIS podcast, visit ois.net . OM